Two Sigma Investments, LP Kala Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.25 - $11.7 $2,568 - $120,205	10,274 Added 24.79%	51,716 $11,000
Q2 2022 Aug 15, 2022	BUY	$0.3 - $1.31 $12,432 - $54,289	41,442 New	41,442 $12,000
Q2 2021 Aug 16, 2021	SELL	$5.06 - $8.15 $867,906 - $1.4 Million	-171,523 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$6.24 - $9.58 $1.85 Million - $2.84 Million	-296,379 Reduced 63.34%	171,523 $1.16 Million
Q4 2020 Feb 16, 2021	BUY	$6.28 - $8.79 $2.94 Million - $4.11 Million	467,902 New	467,902 $3.17 Million
Q3 2020 Nov 16, 2020	SELL	$7.5 - $11.11 $1.27 Million - $1.88 Million	-168,815 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$8.33 - $13.79 $1.21 Million - $2.01 Million	145,615 Added 627.65%	168,815 $1.77 Million
Q1 2020 May 15, 2020	BUY	$3.83 - $8.79 $88,856 - $203,927	23,200 New	23,200 $204,000
Q1 2019 May 15, 2019	SELL	$5.19 - $8.97 $300,376 - $519,147	-57,876 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$4.29 - $9.94 $201,617 - $467,150	46,997 Added 432.0%	57,876 $283,000
Q3 2018 Nov 14, 2018	BUY	$9.54 - $13.87 $103,785 - $150,891	10,879 New	10,879 $107,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.81M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.